Arbutus to Report Fourth Quarter and Year End 2022 Financial Results and Provide Corporate Update

February 16, 2023

https://www.globenewswire.com/news-release/2023/02/16/2609596/14025/en/Arbutus-to-Report-Fourth-Quarter-and-Year-End-2022-Financial-Results-and-Provide-Corporate-Update.html

WARMINSTER, Pa., Feb. 16, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq:ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced that it has scheduled its fourth quarter and year end 2022 financial results and corporate update for Thursday, March 2, 2023. The schedule for the press release and conference call/webcast are as follows:

Read more at globenewswire.com

Related news for (ABUS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.